Intra-Articular Injection of Stromal Cell-Derived Factor 1α Promotes Meniscal Healing via Macrophage and Mesenchymal Stem Cell Accumulation in a Rat Meniscal Defect Model

Int J Mol Sci. 2020 Jul 30;21(15):5454. doi: 10.3390/ijms21155454.

Abstract

The stromal-cell-derived factor-1α (SDF-1) is well-known for playing important roles in the regeneration of tissue by enhancing cell migration. However, the effect of SDF-1 in meniscal healing remains unknown. The purpose of this study is to investigate the effects of intra-articular injection of SDF-1 on meniscus healing in a rat meniscal defect model. The intra-articular SDF-1 injection was performed at meniscectomy and one week later. Macroscopic and histological assessments of the reparative meniscus were conducted at one, two and six weeks after meniscectomy in rats. In the macroscopic evaluation, the SDF-1 group showed an increase in the size of the reparative meniscus at six weeks after meniscectomy compared to the phosphate-buffered saline (PBS) injection (no-treatment) group. Histological findings showed that intra-articular injection of SDF-1 enhanced the migration of macrophages to the site of the regenerative meniscus at one and two weeks after meniscectomy. CD68- and CD163-positive cells in the SDF-1 group at one week after meniscectomy were significantly higher than in the no-treatment group. CD163-positive cells in the SDF-1 group at two weeks were significantly higher than in the no-treatment group. At one week after meniscectomy, there were cells expressing mesenchymal-stem-cell-related markers in the SDF-1 group. These results indicate the potential of regenerative healing of the meniscus by SDF-1 injection via macrophage and mesenchymal stem cell accumulation. In the present study, intra-articular administration of SDF-1 contributed to meniscal healing via macrophage, CD90-positive cell and CD105-positive cell accumulation in a rat meniscal defect model. The SDF-1-CXCR4 pathway plays an important role in the meniscal healing process. For potential clinical translation, SDF-1 injection therapy seems to be a promising approach for the biological augmentation in meniscal injury areas to enhance healing capacity.

Keywords: SDF-1; macrophage; meniscus; mesenchymal stem cell.

MeSH terms

  • Animals
  • Antigens, CD / genetics
  • Antigens, Differentiation, Myelomonocytic / genetics
  • Chemokine CXCL12 / genetics*
  • Chemokine CXCL12 / pharmacology
  • Gene Expression Regulation / drug effects
  • Humans
  • Injections, Intra-Articular
  • Macrophages / metabolism
  • Macrophages / pathology
  • Menisci, Tibial / growth & development
  • Menisci, Tibial / metabolism*
  • Menisci, Tibial / pathology
  • Mesenchymal Stem Cell Transplantation / methods
  • Rats
  • Receptors, CXCR4 / genetics*
  • Receptors, Cell Surface / genetics
  • Regeneration / genetics
  • Tibial Meniscus Injuries / genetics
  • Tibial Meniscus Injuries / pathology
  • Tibial Meniscus Injuries / therapy*
  • Wound Healing / genetics

Substances

  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD163 antigen
  • CXCL12 protein, rat
  • Chemokine CXCL12
  • Cxcr4 protein, rat
  • Receptors, CXCR4
  • Receptors, Cell Surface